Optimized production and concentration of lentiviral vectors containing large inserts
β Scribed by Nadya al Yacoub; Malgorzata Romanowska; Natalie Haritonova; John Foerster
- Book ID
- 102337748
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 331 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.1052
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Generation of high titer lentiviral stocks and efficient virus concentration are central to maximize the utility of lentiviral technology. Here we evaluate published protocols for lentivirus production on a range of transfer vectors differing in size (7.5β13.2 kb). We present a modified virus production protocol robustly yielding useful titers (up to 10^7^/ml) for a range of different transfer vectors containing packaging inserts up to 7.5 kb. Moreover, we find that virus recovery after concentration by ultracentrifugation depends on the size of the packaged inserts, heavily decreasing for large packaged inserts. We describe a fast (4 h) centrifugation protocol at reduced speed allowing high virus recovery even for large and fragile lentivirus vectors. The protocols outlined in the current report should be useful for many labs interested in producing and concentrating high titer lentiviral stocks. Copyright Β© 2007 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract The use of lentiviral vectors as gene delivery vehicles has become increasingly popular in recent years. The growing interest in these vectors has created a strong demand for large volumes of vector stocks, which entails the need for scaleable vector manufacturing procedures. In this wo
## Background: During the past twelve years, lentiviral (lv) vectors have emerged as valuable tools for transgene delivery because of their ability to transduce nondividing cells and their capacity to sustain long-term transgene expression in target cells in vitro and in vivo. however, despite sign
Background Genetically engineered dendritic cells (DC) presenting specific antigens to T cells may be of great interest for immunotherapy. For this reason, the production of transgene-expressing DC derived from CD34+ cells transduced either shortly after ex vivo purification or during their differen